Hi,
You've probably heard someone say it - about a colleague, a friend, maybe yourself:
"They're just taking the easy way out."
GLP-1 drugs like Ozempic and Wegovy are everywhere right now. And so is the controversy. This week, let's cut through both.
WHAT IS GLP-1 AND WHAT DOES IT ACTUALLY DO?
GLP-1 (glucagon-like peptide-1) is a hormone your body already makes naturally. Released by your gut after eating, it signals your brain to reduce hunger, slows digestion so you feel full longer, and helps manage blood sugar after meals.
The problem? Natural GLP-1 breaks down in about two minutes.
Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are synthetic versions engineered to last up to a week — keeping that "I'm full, stop eating" signal switched on, constantly.
WHAT THE SCIENCE SHOWS
The clinical trial data is hard to ignore:
Semaglutide: average 15% body weight loss over 68 weeks (STEP trials)
Tirzepatide: up to 22% body weight reduction — among the highest ever recorded in obesity medicine
Additional benefits: reductions in cardiovascular events, blood pressure, and type 2 diabetes risk
There are also early signals around reduced inflammation and effects on addictive behaviours — though that research is still developing.
THE REAL RISKS (NOT THE HEADLINES)
Side effects are mostly gastrointestinal — nausea, bloating, constipation — most pronounced early on, affecting up to half of users, though they typically settle.
More seriously:
Muscle loss — without adequate protein and resistance training, you lose muscle alongside fat. Studies show lean mass drops ~10% on these medications. Less muscle means a lower resting metabolic rate — your body burns fewer calories at rest.
Weight regain when you stop — and it's worse than most people expect. The STEP 1 trial extension found participants regained roughly two-thirds of lost weight within one year of stopping. For many, full return to baseline occurs by 18 months. Why? Hunger hormones flood back, and your muscles have adapted to burn fewer calories more efficiently. If you haven't protected your muscle mass, your metabolism is now running slower than before you started.
Micronutrient deficiencies — eating much less means nutritional quality matters more, not less.
Rare but serious risks — pancreatitis and gallstones are actively monitored. The BMJ issued a safety warning in early 2026 on pancreatitis-related deaths.
THE MYTH: "IT'S THE EASY WAY OUT"
Genetics, hormones, and environment are real — they drive hunger, blunt fullness signals, and make the body defend stored fat aggressively.
But weight gain still requires a calorie surplus. What these biological factors do is make that surplus far harder to avoid — essentially stacking the deck against you before you've even sat down to eat. GLP-1 drugs work by levelling that playing field. They don't bypass the laws of energy balance. They make them easier to work with.
Nobody calls blood pressure medication "cheating." The same logic applies here.
That said — use the window of reduced appetite to build the habits, muscle, and nutritional quality that protect you if you stop. Because if you don't, the data is clear: most of what you lost comes back.
BEFORE YOU CONSIDER GLP-1s — ASK YOURSELF:
Have you consistently addressed sleep, protein, movement, and meal structure?
Are you working with a GP or registered professional — not a grey-market service?
Do you have a nutrition quality plan for while you're eating less?
Are you doing resistance training to protect your muscle?
What is your exit strategy if you stop?
GLP-1 drugs are a legitimate medical tool. Not magic. Not for everyone. But dismissing them entirely — or chasing them without understanding the biology — are both the wrong move.
P.S. The newsletter is weekly, but I’m posting nutrition tips and gym content every day on Instagram. Drop a follow.
Gabriel Nutrition Coach & Founder | gbMeals | Nutrition Hacks